In-House Health, a Denver, CO-based AI-driven scheduling and management platform for modern nursing teams, has raised $4 million in a seed funding round.
Investors
The funding was led by NEA and TMV, with participation from pre-seed investors Vine Ventures and Longevity Venture Partners, bringing the total investment to date to $5.4 million.
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With nearly $24 billion in cumulative committed capital since the firm's founding in 1977, NEA invests in technology and healthcare companies at all stages in a company's lifecycle, from seed stage through IPO.
TMV is an early-stage venture firm investing in the world's leading entrepreneurs reshaping legacy industries through tech-enabled innovation. Founded in 2016, TMV empowers founders with the capital and go-to-market bench required to reach critical inflection points and scale. With partners on the ground in New York, Chicago, Miami, and London, TMV offers a global alliance for the leaders of tomorrow.
About In-House Health
Founded in 2023 by Ari Brenner, Sergey Vasilenko, and Shachar Har Zvi, In-House Health is an AI-powered tech platform for modern nursing teams. In-House uses predictive analytics and automatic scheduling tools to guide nurse leaders, improving team experience at the bedside, patient safety, and financial outcomes. Its system currently delivers scheduling and clinical insights to the management of more than 800 nurses.
Funding Details
Company: In-House Health
Raised: $4.0M
Round: Seed Round
Funding Month: May 2024
Lead Investors: NEA, TMV
Additional Investors: Vine Ventures, Longevity Venture Partners
Company Website: https://www.inhouse.health/
Software Category: Scheduling and Management Platform
Source: https://www.businesswire.com/news/home/20240508413979/en/